Online inquiry

IVTScrip™ mRNA-Human ABCC4, (Cap 1, 5-Methyl-CTP & Pseudo-UTP, 30 nt-poly(A))   (CAT#: GTTS-WK14148MR)

This product GTTS-WK14148MR is a type of mRNA having 120 nt poly(A) tail and modified with Cap 0 & 5-Methyl-CTP & Pseudo-UTP. It ecodes the ABCC4 protein. This product can be used in Oogenesis phase fetal germ cell-related researches.
Specifications
Product type mRNA
Modified bases 5-Methyl-CTP & Pseudo-UTP
5' Cap Cap 1
Species Human
RefSeq NM_001105515.3
Applications Gene therapy research
Format Powder
Quantity 100 µg
Purification Chromatography
Target Gene
Gene ID 10257
UniProt ID O15439
Download
Download resources about mRNA therapeutics development to boost your research.
CUSTOMER REVIEWS and Q&As

There are currently no Customer reviews or questions for IVTScrip™ mRNA-Human ABCC4, (Cap 1, 5-Methyl-CTP & Pseudo-UTP, 30 nt-poly(A)) (GTTS-WK14148MR). Click the button above to contact us or submit your feedback about this product.

See other products
CAT Product Name Product Type CDs
GTTS-WK12646MR IVTScrip™ mRNA-Human ABCC2, (Cap 1, Pseudo-UTP, 30 nt-poly(A)) mRNA ABCC2
GTTS-WK15874MR IVTScrip™ mRNA-Human AP1G1, (Cap 0, 5-Methyl-CTP, 120 nt-poly(A)) mRNA AP1G1
GTTS-WK26751MR IVTScrip™ mRNA-Human AQP7, (Cap 1, 5-Methyl-CTP & Pseudo-UTP, 120 nt-poly(A)) mRNA AQP7
GTTS-WK16488MR IVTScrip™ mRNA-Human AP3M2, (Cap 0, Pseudo-UTP, 30 nt-poly(A)) mRNA AP3M2
GTTS-WK4927MR IVTScrip™ mRNA-Human SLC16A1, (Cap 1, 5-Methyl-CTP, 120 nt-poly(A)) mRNA SLC16A1
GTTS-WK27646MR IVTScrip™ mRNA-Human AQP1, (Cap 1, 5-Methoxy-UTP, 30 nt-poly(A)) mRNA AQP1
GTTS-WK8755MR IVTScrip™ mRNA-Human ABCF2, (Cap 0, 5-Methyl-CTP & Pseudo-UTP, 120 nt-poly(A)) mRNA ABCF2
GTTS-WK17889MR IVTScrip™ mRNA-Human ANKHD1-EIF4EBP3, (Cap 0, 5-Methyl-CTP & Pseudo-UTP, 30 nt-poly(A)) mRNA ANKHD1-EIF4EBP3
All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
webinar

EABR Nanoparticles as a Platform Technology for Hybrid mRNA Vaccine Development

November 20th, 2024, 2 PM–3 PM EST

REGISTER NOW